Authors: Dilts, DA Riesenfeld-Orn, I Fulginiti, JP Ekwall, E Granert, C Nonenmacher, J Brey, RN Cryz, SJ Karlsson, K Bergman, K Thompson, T Hu, B Bruckner, AH Lindberg, AA

Citation: Da. Dilts et al., Phase I clinical trials of aroA aroD and aroA aroD htrA attenuated S-typhivaccines; effect of formulation on safety and immunogenicity, VACCINE, 18(15), 2000, pp. 1473-1484